FDA Issues Complete Response Letter to Nabriva for Intravenous Fosfomycin - Contagionlive.com
FDA Issues Complete Response Letter to Nabriva for Intravenous Fosfomycin Contagionlive.com
The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Nabriva Therapeutics for intravenous fosfomycin (Contepo) for ...
Comments
Post a Comment